Related Experiment Video
Updated: Jan 28, 2026

Assessing Retinal Microglial Phagocytic Function In Vivo Using a Flow Cytometry-based Assay
Published on: October 18, 2016
Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation
1Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, East Jianshe Road, Zhengzhou, 450001, People's Republic of China.
Abstract:
Studies have shown that papaverine can inhibit lipopolysaccharide (LPS)-induced microglial activation. The retinal primary microglia of newborn SD rats were isolated and purified, and a LPS-induced microglia activation model was established. The protein phosphorylation level of the signaling pathway was detected by western blotting. The transcription and expression of TNF-α, IL-1β, and IL-10 were respectively detected by RT-PCR and ELISA to observe the abnormal activation of primary microglia. The cAMP inhibitor Rp-isomer, PKA inhibitor H89, and MEK inhibitor U0126 were separately added to further investigate the role of MEK/Erk in PAP inhibition of primary microglial activation and the relationship between cAMP/PKA and MEK/Erk. It was found that the level of MEK phosphorylation was upregulated after LPS stimulation, which was blocked by 10 μg/ml of papaverine.10μM U0126 significantly inhibited TNF-α and IL-1β and increased IL-10 transcription and expression in retinal microglia (P < 0.01). Both Rp-isomer and H89 upregulated the phosphorylation levels of MEK and Erk. Papaverine may inhibit inflammatory factors and promote the expression of anti-inflammatory factors through the cAMP/PKA and MEK/Erk pathway, thereby inhibiting LPS-induced activation of primary retinal microglia, and the MEK/Erk pathway may be partially regulated by cAMP/PKA, which can provide theoretical basis and experimental basis for its protection of the central nervous system.
Insights
Papaverine inhibits lipopolysaccharide (LPS)-induced microglial activation by modulating the cAMP/PKA and MEK/Erk pathways. This action reduces inflammatory factors and promotes anti-inflammatory factors, offering neuroprotection.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Microglial activation by lipopolysaccharide (LPS) contributes to neuroinflammation.
- Papaverine has demonstrated potential in inhibiting LPS-induced microglial activation.
Purpose of the Study:
- To investigate the role of the MEK/Erk pathway in papaverine's inhibition of primary retinal microglial activation.
- To explore the relationship between the cAMP/PKA and MEK/Erk pathways in this process.
Main Methods:
- Established an LPS-induced primary retinal microglia activation model in SD rats.
- Utilized Western blotting, RT-PCR, and ELISA to detect protein phosphorylation and gene expression.
- Administered cAMP inhibitor Rp-isomer, PKA inhibitor H89, and MEK inhibitor U0126.
Main Results:
- LPS upregulated MEK phosphorylation, which was inhibited by papaverine.
- U0126 significantly reduced TNF-α and IL-1β while increasing IL-10 expression.
- Rp-isomer and H89 increased MEK and Erk phosphorylation levels.
Conclusions:
- Papaverine inhibits inflammatory factors and promotes anti-inflammatory factors via cAMP/PKA and MEK/Erk pathways, reducing LPS-induced microglial activation.
- The MEK/Erk pathway is partially regulated by cAMP/PKA, providing a basis for papaverine's neuroprotective effects.
More Related Videos
12:48In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
Published on: May 11, 2015
06:27Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish
Published on: October 27, 2017
Related Concept Videos
Intracellular Signaling Cascades
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
Inhibition of Cdk Activity
Rab Cascades
What is Cell Signaling?